Himalaya Nutravedics’ profit rose, but operating cash stayed negative

Himalaya Nutravedics India Limited reported a Rs 7.40 crore profit for the year ended March 31, 2026, up from Rs 2.23 crore in FY2025, yet its operating activities used Rs 3.83 crore of cash. The restated cash-flow statement shows that growth in receivables and other working-capital items absorbed more cash than operating profit generated.

Why did Himalaya Nutravedics’ operating cash stay negative?

Himalaya Nutravedics’ operating cash stayed negative because working-capital movements exceeded its operating profit before working-capital changes in each of FY2024, FY2025 and FY2026. Working capital is the cash tied up in short-term operating assets and liabilities, including inventory, customer receivables and supplier payables. The company reported operating profit before working-capital changes of Rs 8.11 crore in FY2026, but cash generated from or withheld in operations was negative Rs 3.74 crore.

The cash-flow statement recorded net cash utilised in operating activities of Rs 3.83 crore in FY2026, compared with Rs 1.39 crore in FY2025 and Rs 55.10 lakh in FY2024. Income tax paid added Rs 9.16 lakh to the FY2026 outflow after the negative operating cash generated before tax. The three-year progression means the cash deficit widened as reported profit increased, rather than reversing with higher earnings.

The cash-flow statement was prepared under the indirect method prescribed by Accounting Standard 3, Cash Flow Statements, under Section 133 of the Companies Act, 2013. Under this method, profit before tax is adjusted for non-cash items and changes in operating assets and liabilities, which is why the statement separates the Rs 7.48 crore FY2026 profit before tax from actual cash generated in operations.

How quickly did Himalaya Nutravedics’ revenue and profit increase?

Himalaya Nutravedics’ revenue from operations more than doubled to Rs 43.07 crore in FY2026 from Rs 21.00 crore in FY2025, while profit for the year increased to Rs 7.40 crore from Rs 2.23 crore. Revenue was also higher than the Rs 14.43 crore reported in FY2024, showing that the FY2026 expansion followed two years of sales growth.

Profit before tax rose to Rs 7.48 crore in FY2026 from Rs 2.25 crore in FY2025 and Rs 59.46 lakh in FY2024. Total income reached Rs 43.12 crore in FY2026, including Rs 5.28 lakh of other income, while total expenses were Rs 35.64 crore. The difference produced the reported pre-tax profit, but the cash-flow statement shows that profit recognition did not translate into operating cash during the same year.

Cost of materials consumed rose to Rs 25.91 crore in FY2026 from Rs 13.76 crore in FY2025, broadly alongside the revenue increase. Other expenses increased to Rs 6.14 crore from Rs 2.11 crore, while employee-benefit expense decreased to Rs 2.76 crore from Rs 2.94 crore. Finance costs rose to Rs 34.95 lakh from Rs 31.89 lakh, while long-term borrowings were repaid.

Which balance-sheet items absorbed the most cash?

Himalaya Nutravedics’ trade receivables and inventories were the largest current assets at March 31, 2026, totalling Rs 19.50 crore, and their increase coincided with the operating cash outflow. Trade receivables were Rs 10.59 crore at March 31, 2026, up from Rs 5.64 crore at March 31, 2025 and Rs 1.55 crore at March 31, 2024. Inventories reached Rs 8.92 crore, compared with Rs 3.28 crore and Rs 2.52 crore at the preceding two year-ends.

The FY2026 balance-sheet increase in trade receivables was Rs 4.95 crore, matching a negative Rs 4.95 crore line in the cash-flow statement. The same statement also contains a separate negative Rs 5.63 crore line labelled “Trade receivables”; the supplied restated statement does not explain the duplicate label. It separately reports negative Rs 63.02 lakh from other current assets and a negative Rs 24.88 lakh change in non-current assets.

Total current assets increased to Rs 21.70 crore at March 31, 2026 from Rs 9.12 crore a year earlier, while cash and cash equivalents rose to Rs 1.45 crore from Rs 6.71 lakh. The increase in cash did not arise from operations: the cash-flow statement reported a Rs 5.27 crore financing inflow, partly offset by the operating outflow and Rs 5.79 lakh used in investing activities.

Did financing support Himalaya Nutravedics’ cash balance?

Himalaya Nutravedics’ FY2026 closing cash balance was supported by financing activities rather than operating cash generation. Net cash generated from financing activities was reported at Rs 5.27 crore in FY2026, against Rs 1.44 crore in FY2025. That reported financing inflow exceeded the combined Rs 3.83 crore operating outflow and Rs 5.79 lakh investing outflow, leaving net cash higher by Rs 1.38 crore during FY2026.

The cash-flow statement reports Rs 2.23 crore of proceeds from issuance of shares in FY2026. It also reports negative Rs 3.91 crore under net repayment or proceeds from short-term borrowings, negative Rs 54.00 lakh under long-term borrowings, and Rs 34.95 lakh of interest and finance charges paid, while classifying the overall financing section as a Rs 5.27 crore inflow. The supplied statement does not explain the relationship between these individual reported lines and its financing subtotal.

On the balance sheet, short-term borrowings rose to Rs 5.13 crore at March 31, 2026 from Rs 1.22 crore at March 31, 2025, while long-term borrowings fell to zero from Rs 54.00 lakh. Total current liabilities increased to Rs 7.90 crore from Rs 3.42 crore. Short-term provisions rose to Rs 1.53 crore from Rs 44.30 lakh, whereas trade payables to micro and small enterprises declined to Rs 45.05 lakh from Rs 1.20 crore.

What must change for operating cash to improve?

Himalaya Nutravedics’ operating cash would improve only if cash absorbed by receivables, inventories and other operating assets declines sufficiently relative to operating profit and cash obligations. The company defines its operating cycle as 12 months for current and non-current classification under Schedule III of the Companies Act, 2013. At March 31, 2026, current assets of Rs 21.70 crore were larger than current liabilities of Rs 7.90 crore, leaving capital deployed in short-term assets.

Revenue recognition policy also affects the timing difference because Himalaya Nutravedics recognises goods-sale revenue when significant risks and rewards transfer to the buyer, generally on delivery and customer acceptance, provided collection is probable and revenue can be measured reliably. Revenue is presented net of Goods and Services Tax, returns, trade discounts and volume rebates. This policy determines when sales enter profit, whereas cash conversion depends on customer payments and inventory held.

The supplied financial information does not state a receivables collection plan, inventory-reduction target, customer credit terms or a future working-capital facility. It does state that management estimates include provisions for slow-moving or obsolete inventories. The disclosed records therefore identify the balance-sheet build-up and cash effect, but do not disclose a plan establishing when operating cash might turn positive.

Conclusion

Himalaya Nutravedics combined rapid reported growth with a widening operating cash deficit over FY2024 to FY2026. FY2026 revenue of Rs 43.07 crore and profit of Rs 7.40 crore were accompanied by Rs 3.83 crore of cash used in operations, while trade receivables and inventories reached Rs 10.59 crore and Rs 8.92 crore, respectively. The comparison shows that profitability and cash generation moved in different directions during the three reported years.

The next financial update should show whether receivables, inventories and other current assets grow more slowly than sales, since those categories expanded during the reported period. It should also clarify the two separate FY2026 cash-flow lines both labelled trade receivables and the reported financing subtotal, neither of which is explained in the supplied restated financial statements.